Medroxyprogesterone acetate injectable suspension, USP, 150 mg/mL, 1 mL vials, packaged in a) single dose vial (NDC 0703-6801-01), b) 25-count box single dose vials (NDC 0703-6801-04), Rx only, MFG: Teva Pharma USA

Recall Number: D-1069-2022

Firm: Mckesson Medical-Surgical Inc. Corporate Office

Classification: Class II

Status: Terminated

Report Date: 20220615

Initiation Date: 20220413

Termination Date: 20231130

cGMP deviations: Temperature abuse

Medroxyprogesterone acetate injectable suspension, USP, 150 mg/mL, 1 mL vials, packaged in a) single dose vial (NDC 0703-6801-01), b) 25-count box single dose vials (NDC 0703-6801-04), Rx only, MFG: Teva Pharma USA